# \[e-drug\] Advertising in online journals (cont) **URL:** \ **Category:** e-drug\ **Created:** [April 2, 2002, 10:33pm UTC](https://talk.edrugplus.org/t/e-drug-advertising-in-online-journals-cont/14007 "2002-04-02T22:33:45Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![StaffanSvensson](https://dub1.discourse-cdn.com/flex013/user_avatar/talk.edrugplus.org/staffansvensson/32/351_2.png) [@StaffanSvensson](https://talk.edrugplus.org/u/StaffanSvensson)\ **Post date:** [April 2, 2002, 10:33pm UTC](https://talk.edrugplus.org/t/e-drug-advertising-in-online-journals-cont/14007/1 "2002-04-02T22:33:45Z")
E-drug: Advertising in online journals (cont) --------------------------------------------- I have come across a way of online marketing that differs from those described in the Wall Street Journal article submitted by Joel Lexchin (March 28). It goes like this: Experts are invited to write reviews of various medical topics for a sponsor & advertisement-financed website for physicians. Pharmaceutical companies are asked if they want to place advertisements above the reviews. The review authors receive their payment only after a company has agreed to place an ad by their review. The ads are accompanied by a text that reads "The advertising company has no influence over the content of [site's name]". In my view, there is a clear risk that the authors adapt the contents of their texts in order to attract advertisements and receive their rewards. Staffan Svensson Dept of Clinical Pharmacology Sahlgrenska Univ Hospital, Gothenburg, Sweden "Staffan Svensson" \ -- To send a message to E-Drug, write to: e-drug@usa.healthnet.org To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org in the body of the message type: subscribe e-drug OR unsubscribe e-drug To contact a person, send a message to: e-drug-help@usa.healthnet.org Information and archives: [http://www.healthnet.org/programs/edrug.html](http://www.healthnet.org/programs/edrug.html)